Literature DB >> 28840448

Answer to the Letter to the Editor Concerning "Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism".

Jose Rodríguez-Morató1,2, Albert Goday2,3,4,5, Klaus Langohr1,6, Clara Pérez-Mañá1,7,8, Magí Farré1,7,8, Rafael de la Torre9,10,11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28840448     DOI： 10.1007/s11695-017-2896-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  6 in total

1.  Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy.

Authors:  Timothy S Tracy; Raman Venkataramanan; Douglas D Glover; Steve N Caritis
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

2.  Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers.

Authors:  R J Fontana; K S Lown; M F Paine; L Fortlage; R M Santella; J S Felton; M G Knize; A Greenberg; P B Watkins
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

3.  Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

Authors:  Marika T Granfors; Janne T Backman; Jouko Laitila; Pertti J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2005-10       Impact factor: 6.875

4.  Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.

Authors:  D S Ou-Yang; S L Huang; W Wang; H G Xie; Z H Xu; Y Shu; H H Zhou
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

Review 5.  Assessment of CYP1A2 activity in clinical practice: why, how, and when?

Authors:  Mirko S Faber; Alexander Jetter; Uwe Fuhr
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-09       Impact factor: 4.080

6.  Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Authors:  M V Relling; J S Lin; G D Ayers; W E Evans
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.